Ecolab Inc. v. Ace Property and Casualty Insurance Company

CourtDistrict Court, D. Minnesota
DecidedJune 23, 2025
Docket0:23-cv-01259
StatusUnknown

This text of Ecolab Inc. v. Ace Property and Casualty Insurance Company (Ecolab Inc. v. Ace Property and Casualty Insurance Company) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ecolab Inc. v. Ace Property and Casualty Insurance Company, (mnd 2025).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA

Ecolab Inc., File No. 23-cv-1259 (ECT/ECW)

Plaintiff and Counter-Defendant,

v. OPINION AND ORDER

Ace Property and Casualty Insurance Company,

Defendant and Counter-Claimant.

Christine Haskett and Breanna Katherine Jones, Covington & Burling LLP, San Francisco, CA, and Heather Habes, Covington & Burling LLP, Los Angeles, CA, and Aaron M. Johnson and O. Joseph Balthazor, Jr., Taft Stettinius & Hollister LLP, Minneapolis, MN, for Plaintiff and Counter-Defendant Ecolab Inc.

Lawrence Klein, Dac Beachcroft, New York, NY, and Joel T. Wiegert, Hinshaw & Culbertson LLP, Minneapolis, MN, for Defendant and Counter-Claimant Ace Property and Casualty Insurance Company.

The overarching issue in this diversity case is whether Defendant Ace Property and Casualty Insurance Company1 must cover losses that Plaintiff Ecolab incurred in defending and settling fifteen California-venued personal-injury lawsuits. The plaintiffs in those suits alleged they sustained injuries caused by exposure to Ecolab’s OxyCide disinfectant product.

1 Though “Ace Property and Casualty Insurance Company” is the sued defendant, neither party uses this corporate name. Ecolab refers to Ace as “Chubb.” Defendant refers to itself as “ACE.” This order adopts Defendant’s nomenclature and refers to Defendant as “ACE.” Hoping to streamline proceedings, the parties stipulated that Ecolab could bring an early, partial summary-judgment motion. The motion first seeks a decision regarding

whether Minnesota or California applies to the coverage dispute. If Minnesota law applies, the motion next seeks a decision regarding how Minnesota law affects Ecolab’s retained-limit exposure under the ACE polices with respect to one of the California suits— the “Slamer” case. Though the choice-of-law issue is not clear-cut, I conclude that Minnesota law governs the coverage dispute, largely because Minnesota has a greater “governmental

interest” in the case than California. And I conclude that Minnesota law requires Ecolab to exhaust one retained limit for the Slamer case because the case arose from a “discrete and identifiable event,” as the Minnesota Supreme Court defines this insurance-coverage concept. I2

Ecolab and its OxyCide product. Ecolab is incorporated under Delaware law and maintains its principal place of business in Minnesota. First Am. Compl. [ECF No. 106] ¶ 2. Ecolab “provides water, hygiene, and infection prevention solutions and services.” Id. Ecolab’s OxyCide product is “a one-step disinfectant for use in hospitals that is effective against Clostridioides difficile (formerly Clostridium difficile) spores, Candida auris and a

broad spectrum of other organisms.” OxyCide Daily Disinfectant Cleaner, Ecolab,

2 Part I describes undisputed facts at a high level. Other more specific facts will be considered in analyzing the choice-of-law and allocation issues addressed in Part II. Page citations are to a document’s CM/ECF pagination appearing in the upper righthand corner, not to a document’s original pagination. https://www.ecolab.com/offerings/concentrated-cleaners-and-disinfectants/OxyCide- daily-disinfectant-cleaner (last visited June 22, 2025). Ecolab manufactures OxyCide

“primarily in a facility in Martinsburg, West Virginia.” ECF No. 131 ¶ 3. “Ecolab does not manufacture OxyCide in Minnesota, and more generally, does not perform substantial commercial manufacturing in Minnesota.” Id.3 ACE and its issuance of the relevant policies to Ecolab. ACE is incorporated under Pennsylvania law and maintains its principal place of business in Philadelphia. First Am. Compl. ¶ 3. ACE issued nine successive liability insurance policies to Ecolab beginning

in December 2011 and continuing through December 2020. First Am. Compl. ¶ 9; ECF

3 ACE says that Ecolab manufactures OxyCide in Minnesota, but this factual contention is not supported in the way Rule 56 requires. To show that Ecolab manufactures OxyCide in Minnesota, ACE relied on a document entitled “S&P Capital IQ” that describes “Ecolab Inc. | Products & Services.” ECF No. 124-4. The document displays information in five categories: “Product Name,” “Company,” “Primary Industry,” “Geography,” and “Source.” Id. The document’s third page (the fourth page on CM/ECF), references “OxyCide” in the “Product Name” category and “Minnesota” in the corresponding “Geography” category. Id. at 4. In a declaration accompanying this document, ACE’s counsel testifies that the “Geography” category represents “the geography of the product’s manufacture.” ECF No. 124 ¶ 6. The document does not give definitions for any of its five categories, see ECF No. 124-4, and “Geography” as a category could mean many things. Why, for example, couldn’t it mean the location of the Ecolab division or department responsible for overseeing OxyCide’s sales and marketing? No explanation is provided to show why “Geography” means the place of each listed product’s manufacture. See ECF No. 124 ¶ 6. Without this information, I cannot conclude that this aspect of the supporting declaration is “made on personal knowledge” or “show[s] that the . . . declarant is competent to testify on the matters stated.” Fed. R. Civ. P. 56(c)(4). In any event, it seems ACE no longer relies on this assertion. In response to ACE’s allegation that Ecolab manufactures OxyCide in Minnesota, Ecolab filed a declaration from its treasury director who testified that OxyCide is manufactured primarily in West Virginia and not in Minnesota. ECF No. 131 ¶ 3. ACE did not address this evidence in its sur-reply brief. See generally ECF No. 139. Nor did it continue to press the claim that Ecolab manufactures OxyCide in Minnesota. Id. No. 120 ¶ 3; see also ECF No. 120-1. The policies were brokered by Marsh USA Inc. at its New York office and issued to Ecolab at its St. Paul, Minnesota headquarters. See ECF

No. 120-1 at 2. A Minnesota-based Ecolab employee—its Treasury Director, Risk Management—oversaw “the insurance policy underwriting process with Ecolab’s brokers and insurers, including ACE.” ECF No. 120 ¶ 2; see ECF No. 123 at 12. The at-issue policy terms. The parties agree that the material terms are identical across all nine policies ACE issued to Ecolab. See ECF No. 118 at 7 n.3; ECF No. 123 at 8–9. The policies required ACE to “pay on behalf of [Ecolab] those sums in excess of the

‘retained limit’ that [Ecolab] becomes legally obligated to pay as damages because of ‘bodily injury.’” ECF No. 120-1 at 9. Ecolab’s “retained” limit was $5 million per occurrence and $15 million in the aggregate. Id. at 94. The policies covered “‘bodily injury’ . . . caused by an ‘occurrence’ . . . during the ‘policy period.’” Id. at 9. With respect to “bodily injury,” the policies defined “occurrence” to mean “an accident, including

continuous or repeated exposure to substantially the same general harmful conditions. All such exposure to substantially the same general conditions shall be considered as arising out of the same ‘occurrence’, regardless of the frequency or repetition thereof, or the number of claimants.” Id. at 25. The policies provided coverage up to $25 million per occurrence and $25 million in the aggregate. Id. at 2. No policy contained a choice-of-law

provision. The underlying OxyCide lawsuits generally. Plaintiffs across the United States sued Ecolab for alleged bodily injuries arising from exposure to OxyCide. The plaintiffs in the underlying lawsuits generally alleged that OxyCide includes “dangerous chemicals and compounds that are known to cause adverse health effects,” including its chemical component “peracetic acid . . . a known asthmagen (asthma causing substance) and

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Allstate Insurance v. Hague
449 U.S. 302 (Supreme Court, 1981)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Northern States Power Co. v. Fidelity & Casualty Co. of New York
523 N.W.2d 657 (Supreme Court of Minnesota, 1994)
Cargill, Inc. v. Evanston Insurance Co.
642 N.W.2d 80 (Court of Appeals of Minnesota, 2002)
Nodak Mutual Insurance Co. v. American Family Mutual Insurance Co.
604 N.W.2d 91 (Supreme Court of Minnesota, 2000)
Burks v. Abbott Laboratories
639 F. Supp. 2d 1006 (D. Minnesota, 2009)
Lommen v. City of East Grand Forks
522 N.W.2d 148 (Court of Appeals of Minnesota, 1994)
Domtar, Inc. v. Niagara Fire Insurance Co.
563 N.W.2d 724 (Supreme Court of Minnesota, 1997)
Jepson v. General Casualty Co. of Wisconsin
513 N.W.2d 467 (Supreme Court of Minnesota, 1994)
Schumacher v. Schumacher
676 N.W.2d 685 (Court of Appeals of Minnesota, 2004)
Milkovich v. Saari
203 N.W.2d 408 (Supreme Court of Minnesota, 1973)
Hime v. State Farm Fire & Casualty Co.
284 N.W.2d 829 (Supreme Court of Minnesota, 1979)
Myers v. Government Employees Insurance Co.
225 N.W.2d 238 (Supreme Court of Minnesota, 1974)
SCSC Corp. v. Allied Mutual Insurance Co.
536 N.W.2d 305 (Supreme Court of Minnesota, 1995)
In Re Silicone Implant Insurance Coverage Litigation
667 N.W.2d 405 (Supreme Court of Minnesota, 2003)
Blake Marine Group v. CarVal Investors LLC
829 F.3d 592 (Eighth Circuit, 2016)
Medical Graphics Corp. v. Hartford Fire Insurance
171 F.R.D. 254 (D. Minnesota, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
Ecolab Inc. v. Ace Property and Casualty Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ecolab-inc-v-ace-property-and-casualty-insurance-company-mnd-2025.